MK-677: Natty or Not? | Still Natty Abstract gradient background for Still Natty peptides guide
Back to Peptides

MK-677

Natty
growth hormonemuscle gainsleepbone densityanti-agingoral

What It Does

Increases lean muscle mass, bone density, and deep sleep quality. Enhances recovery and tissue healing. Risk of blood sugar issues.

Natty Status Classification

This peptide is generally considered within the natty realm by some in the fitness community, particularly when used for therapeutic healing purposes. However, opinions vary, and competitive natural bodybuilding organizations may have different stances. Always check your federation's specific rules if you compete.

Description

Oral ghrelin receptor agonist boosting GH/IGF-1 and sleep quality. Causes insulin resistance and glucose issues. Not FDA-approved, development discontinued.

Application Methods

  • Oral

Product Names

  • Ibutamoren Mesylate
  • MK-677

Benefits

  • GH secretion increased 50-97% above baseline
  • Significant IGF-1 elevation with preserved pulsatile secretion
  • Lean body mass increase (1.1 kg over 12 months in elderly)
  • Improved bone mineral density and bone formation markers
  • Dramatic sleep improvement (20-50% increase in REM sleep)
  • 50% increase in slow-wave sleep in young subjects
  • Enhanced recovery and tissue healing
  • Improved skin, hair, and nail quality
  • Increased appetite (can be beneficial or adverse)
  • Oral administration (no injections required)

Dosage Levels

  • Low dose: 10-15mg daily (ideal for sleep, longevity, first-time users)
  • Moderate dose: 20-25mg daily (clinical trial standard, body recomposition)
  • High dose: 30mg+ daily (advanced users, not recommended due to side effects)
  • Timing - Before bed: Maximizes sleep benefits, reduces daytime hunger
  • Timing - Morning: Increases appetite throughout day (useful for bulking)
  • Cycle duration: 8-12 weeks recommended, up to 16 weeks for intermediate
  • Half-life: 24 hours (once daily dosing sufficient)
  • Monitor fasting glucose and insulin sensitivity during use

Related Peptides

Last Updated: 10/19/2025